Literature DB >> 27183613

Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells.

Thomas Verrier1, Naoko Satoh-Takayama2, Nicolas Serafini3, Solenne Marie3, James P Di Santo4, Christian A J Vosshenrich3.   

Abstract

Group 3 innate lymphoid cells (ILC3) actively participate in mucosal defense and homeostasis through prompt secretion of IL-17A, IL-22, and IFN-γ. Reports identify two ILC3 lineages: a CCR6(+)T-bet(-) subset that appears early in embryonic development and promotes lymphoid organogenesis and a CCR6(-)T-bet(+) subset that emerges after microbial colonization and harbors NKp46(+) ILC3. We demonstrate that NKp46 expression in the ILC3 subset is highly unstable. Cell fate mapping using Ncr1(CreGFP) × Rosa26(RFP) mice revealed the existence of an intestinal RFP(+) ILC3 subset (Ncr1(FM)) lacking NKp46 expression at the transcript and protein levels. Ncr1(FM) ILC3 produced more IL-22 and were distinguishable from NKp46(+) ILC3 by differential CD117, CD49a, DNAX accessory molecule-1, and, surprisingly, CCR6 expression. Ncr1(FM) ILC3 emerged after birth and persisted in adult mice following broad-spectrum antibiotic treatment. These results identify an unexpected phenotypic instability within NKp46(+) ILC3 that suggests a major role for environmental signals in tuning ILC3 functional plasticity.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183613     DOI: 10.4049/jimmunol.1502673

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.

Authors:  Wenqing Zhou; Gregory F Sonnenberg
Journal:  Trends Immunol       Date:  2020-07-06       Impact factor: 16.687

2.  Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice.

Authors:  Xiaopeng Wu; Achia Khatun; Moujtaba Y Kasmani; Yao Chen; Shikan Zheng; Samantha Atkinson; Christine Nguyen; Robert Burns; Elizabeth J Taparowsky; Nita H Salzman; Timothy W Hand; Weiguo Cui
Journal:  J Exp Med       Date:  2022-09-01       Impact factor: 17.579

3.  Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells.

Authors:  Maria Pokrovskii; Jason A Hall; David E Ochayon; Ren Yi; Natalia S Chaimowitz; Harsha Seelamneni; Nicholas Carriero; Aaron Watters; Stephen N Waggoner; Dan R Littman; Richard Bonneau; Emily R Miraldi
Journal:  Immunity       Date:  2019-07-02       Impact factor: 31.745

4.  The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine.

Authors:  Adam K Savage; Hong-Erh Liang; Richard M Locksley
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

5.  Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.

Authors:  Daniel R Calabrese; Emily Aminian; Benat Mallavia; Fengchun Liu; Simon J Cleary; Oscar A Aguilar; Ping Wang; Jonathan P Singer; Steven R Hays; Jeffrey A Golden; Jasleen Kukreja; Daniel Dugger; Mary Nakamura; Lewis L Lanier; Mark R Looney; John R Greenland
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 6.  Dynamic regulation of innate lymphoid cells in the mucosal immune system.

Authors:  Fei Shao; Dou Yu; Pengyan Xia; Shuo Wang
Journal:  Cell Mol Immunol       Date:  2021-05-12       Impact factor: 22.096

Review 7.  Functional and phenotypic heterogeneity of group 3 innate lymphoid cells.

Authors:  Felipe Melo-Gonzalez; Matthew R Hepworth
Journal:  Immunology       Date:  2017-01-03       Impact factor: 7.397

Review 8.  Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System.

Authors:  David R Withers; Matthew R Hepworth
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

9.  Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches.

Authors:  Sae-Hae Kim; Byeol-Hee Cho; Hiroshi Kiyono; Yong-Suk Jang
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

Review 10.  NKp30 - A prospective target for new cancer immunotherapy strategies.

Authors:  Pedro F Pinheiro; Gonçalo C Justino; M Matilde Marques
Journal:  Br J Pharmacol       Date:  2020-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.